Last updated 25 days ago

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

858 patients around the world
Available in Puerto Rico, Brazil, Argentina, Chile
Sanofi
5Research sites
858Patients around the world
This study is for people with
Multiple sclerosis
Secondary progressive multiple sclerosis
Requirements for the patient
To 60 Years
All Gender
Medical requirements
Sites
Instituto de Neurología Cognitiva (INECO)
Recruiting
Marcelo Torcuato de Alvear 1632, C1021 Cdad. Autónoma de Buenos Aires, Argentina
L2IP Instituto de Pesquisas Clínicas
Recruiting
SGAS 613, Conj. E Bloco A , Sala 06 - Subsolo , Asa Sul - Brasília/DF, CEP: 70.200-730
Clínica Neurologica e Neurocirurgica de Joinville Ltda
Recruiting
Rua Miguel Couto, 133 – Anita Gabribaldi – Joinville/SC – CEP 89202-190
CPQuali Pesquisa Clínica
Recruiting
Avenida Angélica, 916 Conjunto 506 - São Paulo 01228-000
Jordy Sinapse Medicina LTDA ME
Recruiting
Avenida Sabiá, 418 - Moema/São Paulo, SP - CEP:04515-000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy